CN111925308B - 一种光催化合成n-取代砜二亚胺的方法 - Google Patents
一种光催化合成n-取代砜二亚胺的方法 Download PDFInfo
- Publication number
- CN111925308B CN111925308B CN202010813444.2A CN202010813444A CN111925308B CN 111925308 B CN111925308 B CN 111925308B CN 202010813444 A CN202010813444 A CN 202010813444A CN 111925308 B CN111925308 B CN 111925308B
- Authority
- CN
- China
- Prior art keywords
- phenyl
- diimine
- sulfone diimine
- synthesizing
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910000071 diazene Inorganic materials 0.000 title claims abstract description 86
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 title claims abstract description 83
- 150000003457 sulfones Chemical class 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 57
- 230000001699 photocatalysis Effects 0.000 title claims abstract description 31
- 230000002194 synthesizing effect Effects 0.000 title abstract description 35
- 238000007146 photocatalysis Methods 0.000 title abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- -1 sulfone diimine compound Chemical class 0.000 claims abstract description 19
- 239000011941 photocatalyst Substances 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 6
- 229910052741 iridium Inorganic materials 0.000 claims abstract description 6
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical group [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000010 aprotic solvent Substances 0.000 claims abstract description 5
- 150000007529 inorganic bases Chemical class 0.000 claims abstract description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims abstract description 3
- 239000011261 inert gas Substances 0.000 claims abstract description 3
- 230000001678 irradiating effect Effects 0.000 claims abstract description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- 238000003786 synthesis reaction Methods 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 8
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 150000001336 alkenes Chemical class 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
- 235000011181 potassium carbonates Nutrition 0.000 claims description 5
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 4
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 229930192474 thiophene Natural products 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical group 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 8
- 238000005286 illumination Methods 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 72
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 18
- 238000005160 1H NMR spectroscopy Methods 0.000 description 18
- 238000012512 characterization method Methods 0.000 description 18
- JCDWETOKTFWTHA-UHFFFAOYSA-N methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=CC=C1 JCDWETOKTFWTHA-UHFFFAOYSA-N 0.000 description 15
- 125000005555 sulfoximide group Chemical group 0.000 description 4
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 2
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- VMHANKFHVYWTGK-UHFFFAOYSA-N 1-(benzenesulfonylmethyl)-4-methylbenzene Chemical group C1=CC(C)=CC=C1CS(=O)(=O)C1=CC=CC=C1 VMHANKFHVYWTGK-UHFFFAOYSA-N 0.000 description 1
- FJLFSYRGFJDJMQ-UHFFFAOYSA-N 1-bromo-4-methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=C(Br)C=C1 FJLFSYRGFJDJMQ-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical group CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- JEVYVLLSVHNREX-UHFFFAOYSA-N 1-chloro-4-[(4-chlorophenyl)methylsulfonylmethyl]benzene Chemical compound C1=CC(Cl)=CC=C1CS(=O)(=O)CC1=CC=C(Cl)C=C1 JEVYVLLSVHNREX-UHFFFAOYSA-N 0.000 description 1
- KAZUCVUGWMQGMC-UHFFFAOYSA-N 1-methoxy-4-methylsulfonylbenzene Chemical group COC1=CC=C(S(C)(=O)=O)C=C1 KAZUCVUGWMQGMC-UHFFFAOYSA-N 0.000 description 1
- YYDNBUBMBZRNQQ-UHFFFAOYSA-N 1-methyl-4-methylsulfonylbenzene Chemical compound CC1=CC=C(S(C)(=O)=O)C=C1 YYDNBUBMBZRNQQ-UHFFFAOYSA-N 0.000 description 1
- PCLKVJBRTCQNDU-UHFFFAOYSA-N 2-methylsulfonylpyridine Chemical group CS(=O)(=O)C1=CC=CC=N1 PCLKVJBRTCQNDU-UHFFFAOYSA-N 0.000 description 1
- BNYLGFINMVZZGA-UHFFFAOYSA-N 2-methylsulfonylthiophene Chemical group CS(=O)(=O)C1=CC=CS1 BNYLGFINMVZZGA-UHFFFAOYSA-N 0.000 description 1
- PWBIAEVWEMNPLY-UHFFFAOYSA-N 3-methylsulfonylthiophene Chemical group CS(=O)(=O)C=1C=CSC=1 PWBIAEVWEMNPLY-UHFFFAOYSA-N 0.000 description 1
- QVHPIEJTHBPITM-UHFFFAOYSA-N 4-methylsulfonylpyridine Chemical group CS(=O)(=O)C1=CC=NC=C1 QVHPIEJTHBPITM-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- ILLZAYJNRDBADG-UHFFFAOYSA-N F[S+]1C=NCC1 Chemical compound F[S+]1C=NCC1 ILLZAYJNRDBADG-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical group BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- FABCMLOTUSCWOR-UHFFFAOYSA-N benzenesulfonylmethylbenzene Chemical compound C=1C=CC=CC=1S(=O)(=O)CC1=CC=CC=C1 FABCMLOTUSCWOR-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- SSGWVSXDZMOXDW-UHFFFAOYSA-N butylsulfonylbenzene Chemical compound CCCCS(=O)(=O)C1=CC=CC=C1 SSGWVSXDZMOXDW-UHFFFAOYSA-N 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- VBQUDDWATQWCPP-UHFFFAOYSA-N ethylsulfonylbenzene Chemical compound CCS(=O)(=O)C1=CC=CC=C1 VBQUDDWATQWCPP-UHFFFAOYSA-N 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- KYPIULIVYSQNNT-UHFFFAOYSA-N prop-2-enylsulfonylbenzene Chemical compound C=CCS(=O)(=O)C1=CC=CC=C1 KYPIULIVYSQNNT-UHFFFAOYSA-N 0.000 description 1
- IJTSQCOXRMHSCS-UHFFFAOYSA-N propan-2-ylsulfonylbenzene Chemical group CC(C)S(=O)(=O)C1=CC=CC=C1 IJTSQCOXRMHSCS-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- GLBQVJGBPFPMMV-UHFFFAOYSA-N sulfilimine Chemical compound S=N GLBQVJGBPFPMMV-UHFFFAOYSA-N 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 229960001479 tosylchloramide sodium Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/10—Compounds containing sulfur atoms doubly-bound to nitrogen atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/122—Incoherent waves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
- B01J35/39—Photocatalytic properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J8/00—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4277—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
- B01J2231/4283—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using N nucleophiles, e.g. Buchwald-Hartwig amination
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Electromagnetism (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
本发明公开了一种光催化合成N‑取代砜二亚胺的方法,该方法包含将砜二亚胺化合物、溴化物、无机碱和光催化剂于封闭的反应管中,在惰性气体氛围下,于非质子溶剂中,在室温下用白光灯照射反应管进行反应,经后处理后得到N‑取代砜二亚胺。其中,光催化剂选用铱催化剂。本发明的方法采用光催化剂,在室温下光照条件下即可进行反应,反应条件温和,而且适用的底物范围广泛。
Description
技术领域
本发明涉及一种合成N-取代砜二亚胺的方法,具体涉及一种光催化合成N-取代砜二亚胺的方法。
背景技术
在1964年,Cogliano andBraude等首次合成了砜二亚胺(sulfondiimine),因为其相对复杂和困难的合成路线,只有少数化学家关注和研究砜二亚胺的化学合成,而且,目前只有少量的砜二亚胺类化合物的合成和应用被报道。
近年来,砜二亚胺的类似物亚砜亚胺(sulfoximine)因其生化活性受到了化学界的关注。许多亚砜亚胺类化合物被应用到药物和农药领域。除此之外,亚砜亚胺还可以被用作高效的手性配体和手性辅基。与相对发展成熟的亚砜亚胺类化合物相比,与其结构相似的砜二亚胺类化合物受到的关注很少,这意味着砜二亚胺类化合物具有极大的发展潜力。
最早的合成N,N-无取代的砜二亚胺的方法是用相应的硫醚与次氯酸叔丁基酯(或氯亚明)以及液氨反应(参见反应式a),这种合成方法可以以较高产率制得S,S-二烷基取代的砜二亚胺。但是,这一方法无法合成S-芳基取代砜二亚胺和S,S-二芳基取代的砜二亚胺。
在1973年,Oae报道了用硫亚胺与氯亚明(Chloramine-T)合成砜二亚胺的新方法,这一方法可以高效的制备S,S-二芳基取代的砜二亚胺,但是无法用于合成S-烷基取代砜二亚胺和S,S-二烷基取代的砜二亚胺(参见反应式b)。
近年,Yoshimura教授课题组报道了用S-氟噻唑炔合成S,S-二芳基取代的砜二亚胺的新方法,但是这一方法同样无法用于合成S-烷基取代砜二亚胺(参见反应式c)。
最近,Bolm教授课题组报道了通过硫亚胺盐的氧化亚胺化高效制备砜二亚胺的新方法(参见反应式d),这一方法可以合成S-烷基S-芳基取代砜二亚胺,用于合成S,S-二芳基取代的砜二亚胺和S,S-二烷基取代的砜二亚胺也能得到较好的结果。
对于N,N-二取代砜二亚胺的合成,目前主要是通过NH-砜二亚胺与相应底物的偶联反应来实现的(参见反应式e)。
尽管上述砜二亚胺的合成取得了很大的进步,但是仍有许多问题亟待解决:(1)砜二亚胺的底物很有限,取代基只是局限在少数常见官能团;(2)N-C偶联反应需要很苛刻的反应条件和很活泼的取代基团。因此,发展一种温和的、高效的合成N-取代砜二亚胺的方法仍然是十分必要的。
发明内容
本发明的目的是提供一种光催化合成N-取代砜二亚胺的方法,解决了现有N-取代砜二亚胺合成底物局限的问题,适用的底物范围广,而且反应条件温和,后处理简单。
为了达到上述目的,本发明提供了一种光催化合成N-取代砜二亚胺的方法,其特征在于,该方法包含:
将具有如式A所示的砜二亚胺化合物、具有如式B所示的溴化物、无机碱和光催化剂于封闭的反应管中,在惰性气体氛围下,于非质子溶剂中,在室温下用白光灯照射反应管进行反应,经后处理后得到具有如式C所示的N-取代砜二亚胺。
其中,所述光催化剂选用铱催化剂;R1选自芳香基、五元或六元芳香杂环中的任意一种;R2选自芳香基、除叔丁基外的C1~C4的烷烃中的任意一种;R4选自H或供电子基;R3选自芳香基或C1~C4的烷烃。R2为叔丁基时,位阻太大没有产物。
所述铱催化剂的结构式为:
优选地,所述R1选自无取代或取代苯基、五元或六元含氮芳香杂环、五元含硫芳香杂环和五元含氧芳香杂环中的任意一种;所述R2选自无取代或取代苯基、苄基、除叔丁基外的C1~C4的饱和烷烃、C3~C4的烯烃中的任意一种。
优选地,所述R3选自苯基、C1~C4的饱和烷烃和C2~C4的烯烃中的任意一种。
优选地,所述R3选自苯基、甲基、乙基、正丙基、乙烯中的任意一种。
优选地,所述白光灯的功率为5W。
优选地,所述无机碱包含:碳酸盐和/或碳酸氢盐;所述碳酸盐包含:碳酸钠和/或碳酸钾;所述碳酸氢盐包含:碳酸氢钠和/或碳酸氢钾。
优选地,所述非质子溶剂包含:四氢呋喃、甲苯和乙醚中的任意一种或两种以上。
优选地,所述后处理采用硅胶柱层析。
优选地,所述反应时间为6~24h。
本发明的光催化合成N-取代砜二亚胺的方法,解决了现有N-取代砜二亚胺合成底物局限的问题,具有以下优点:
本发明的方法,采用光催化剂,在室温下光照条件下即可进行反应,反应条件温和。而且,本发明适用的底物范围广泛,取代基可以为芳香基、烷基、苄基,能够合成S-烷基S-芳基取代砜二亚胺、S-苄基S-芳基取代砜二亚胺和S,S-二芳基取代的砜二亚胺(位阻较大,产率低),但不能合成S,S--二烷基取代砜二亚胺。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
为了对本发明提供的一种光催化合成N-取代砜二亚胺的方法进行更加具体地说明,以下通过实施例1-22进行详细阐述。
实施例1
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
依次称取1mmol甲基苯基砜二亚胺、1.2mmol溴苄、1.2mmol碳酸钾、0.05mmol铱催化剂置于反应管中,用橡胶塞封闭反应管。然后,用Ar气充换气3次。用注射器将2mL THF注入反应管,然后在室温下用5W LED白光灯照射反应管12h。
待反应结束后,将溶剂旋干,硅胶柱层析纯化产物,产物为黄色固体,产率为65%。
实施例1产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.78(m,2H),7.57-7.51(m,3H),7.39(d,J=6.8Hz,2H),7.34-7.25(m,3H),5.11(dd,J1=23.2Hz,J2=12.4Hz,2H),2.83(s,3H);
13C NMR(100MHz,CDCl3)δ137.3,136.4,132.3,129.9,128.2,128.1,127.6,126.2,67.6,36.1。
实施例2
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成乙基苯基砜二亚胺,其它与实施例1的相同,产率为53%。
实施例2产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.70-7.63(m,2H),7.50-7.42(m,3H),7.32-7.31(d,J=7.2Hz,2H),7.25-7.16(m,3H),5.04(q,J=12.4Hz,2H),3.08-2.9(m,2H),1.17(m,3H);
13C NMR(100MHz,CDCl3)δ137.4,134.4,132.3,129.8,128.2,128.1,127.6,126.9,126.2,67.6,45.2,7.9。
实施例3
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成二苯基砜二亚胺,其它与实施例1的相同,产率为5%。
实施例3产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.74(dd,J1=7.6Hz,J2=1.6Hz,4H),7.50-7.44(m,6H),7.41(d,J=6.8Hz,2H),7.33-7.28(m,3H),5.16(s,1H);
13C NMR(100MHz,CDCl3)δ137.4,136.6,132.0,129.8,128.3,127.7,127.6,67.9。
实施例4
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成苄基苯基砜二亚胺,其它与实施例1的相同,产率为73%。
实施例4产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.53-7.50(m,3H),7.43-7.36(m,4H),7.33-7.27(m,4H),7.22(t,J=8.0Hz,2H),6.96(d,J=7.2Hz,2H),5.17-5.09(m,2H),4.50(d,J=12.4Hz,1H),4.10(d,J=12.4Hz,1H);
13C NMR(100MHz,CDCl3)δ137.5,133.1,132.5,130.6,129.4,129.0,128.7,128.2,128.1,127.6,127.5,67.7,57.7。
实施例5
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成甲基对甲苯基砜二亚胺,其它与实施例1的相同,产率为79%。
实施例5产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.74-7.09(m,2H),7.38(d,J=6.8Hz,2H),7.32-7.26(m,3H),7.02(dt,J1=10.0Hz,J2=2.8Hz,2H),5.09(dd,J1=25.6Hz,J2=12.4Hz,2H),3.84(s,3H),2.80(s,3H);
13C NMR(100MHz,CDCl3)δ137.3,128.4,128.2,128.1,127.59,126.9,115.4,67.5,55.6,36.1。
实施例6
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成对甲氧基苯基甲基砜二亚胺,其它与实施例1的相同,产率为72%。
实施例6产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.73(d,J=8Hz,2H),7.39-7.28(m,7H),5.11(dd,J1=26.0Hz,J2=12.4Hz,2H),2.92(s,3H),2.42(s,3H);
13C NMR(100MHz,CDCl3)δ143.6,137.1,130.7,128.3,128.1,127.73,126.7,111.6,67.8,52.2,35.6,21.6。
实施例7
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成对氯苯基甲基砜二亚胺,其它与实施例1的相同,产率为60%。
实施例7产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.74-7.70(m,2H),7.53-7.50(m,2H),7.38(d,J=7.2Hz,2H),7.33-7.27(m,3H),5.10(dd,J1=23.2Hz,J2=12.0Hz,2H),2.80(s,3H);
13C NMR(100MHz,CDCl3)δ138.9,137.2,135.0130.3,128.3,128.2,127.7,127.6,67.7,36.1。
实施例8
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成对溴苯基甲基砜二亚胺,其它与实施例1的相同,产率为64%。
实施例8产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.69-7.63(m,4H),7.38(d,J=8Hz,2H),7.34-7.27(m,3H),5.13(dd,J1=23.6Hz,J2=12.4Hz,2H),2.82(s,3H);
13C NMR(100MHz,CDCl3)δ137.2,135.7,133.2,128.7,128.3,128.3,127.7,127.2,126.8,76.7,67.8,36.0。
实施例9
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的溴苄换成烯丙基溴,其它与实施例1的相同,产率为64%。
实施例9产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.88(m,2H),7.67-7.59(m,3H),6.74(dd,J=16.4,9.6Hz,1H),6.51(d,J=16.4Hz,1H),6.16(d,J=9.6,Hz,1H),5.11(dd,J1=23.2Hz,J2=12.4Hz,2H),2.84(s,3H);
13C NMR(100MHz,CDCl3)δ137.5,136.9,136.3,134.0,129.8,129.4,128.5,128.4,128.1,128.0,68.1,36.3。
实施例10
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的溴苄换成溴丁烷,其它与实施例1的相同,产率为59%。
实施例10产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.97-7.95(m,2H),7.62-7.59(m,1H),7.56-7.52(m,2H),3.17-3.07(m,2H),2.84(s,3H),1.78-1.61(m,2H),1.35-1.19(m,2H),0.84(t,J=7.0Hz,3H);
13C NMR(100MHz,CDCl3)δ142.1,133.0,129.1,128.4,57.5,31.2,27.9,22.3,13.9。
实施例11
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的碳酸钾换成碳酸钠,其它与实施例1的相同,产率为62%。
实施例12
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的碳酸钾换成碳酸氢钾,其它与实施例1的相同,产率为58%。
实施例13
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的THF换成甲苯,其它与实施例1的相同,产率为61%。
实施例14
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的THF换成乙醚,其它与实施例1的相同,产率为62%。
实施例15
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成2-吡啶基甲基砜二亚胺,其它与实施例1的相同,产率为71%。
实施例15产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ8.62-8.64(m,1H),8.03(d,J=7.5Hz,1H),7.64-7.57(m,2H),7.39(d,J=6.8Hz,2H),7.34-7.25(m,3H),5.14(dd,J1=23.2Hz,J2=12.4Hz,2H),2.82(s,3H);
13C NMR(100MHz,CDCl3)δ155.9,150.1,138.4,136.4,129.9,128.2,128.1,127.6,125.9,125.3,67.6,36.1。
实施例16
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成4-吡啶基甲基砜二亚胺,其它与实施例1的相同,产率为74%。
实施例16产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ8.21-8.04(m,2H),8.03(m,2H),7.41-7.33(m,2H),7.34-7.25(m,3H),5.13(dd,J1=23.2Hz,J2=12.4Hz,2H),2.81(s,3H);
13C NMR(100MHz,CDCl3)δ155.4,150.3,137.2,136.1,129.8,128.2,128.1,127.6,125.9,67.9,36.0。
实施例17
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成2-噻吩基甲基砜二亚胺,其它与实施例1的相同,产率为68%。
实施例17产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.67-7.63(m,3H),7.58(dd,J=1.3,3.8,1H),7.35-7.30(m,3H),7.07(dd,J=3.7,5.1Hz,1H),5.18(dd,J1=23.2Hz,J2=12.4Hz,2H),3.03(s,3H);
13C NMR(125MHz,CDCl3)δ135.8,134.2,133.3,133.1,130.0,129.3,127.7,127.7,100.3,36.9。
实施例18
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成3-噻吩基甲基砜二亚胺,其它与实施例1的相同,产率为64%。
实施例18产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.65-7.60(m,3H),7.42(s,1H),7.37-7.31(m,3H),7.07(m,1H),5.20(dd,J1=23.2Hz,J2=12.4Hz,2H),2.98(s,3H);
13C NMR(125MHz,CDCl3)δ136.9,135.1,133.9,133.2,130.1,129.4,128.1,127.7,101.3,36.3。
实施例19
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成4-甲基苄基苯基砜二亚胺,其它与实施例1的相同,产率为70%。
实施例19产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.53-7.50(m,2H),7.43-7.36(m,4H),7.33-7.27(m,4H),7.23(m,2H),7.05(d,J=7.2Hz,2H),5.16-5.05(m,2H),4.52(d,J=12.4Hz,1H),4.01(d,J=12.4Hz,1H),2.84(s,3H);
13C NMR(100MHz,CDCl3)δ138.3,134.7,133.3,131.6,129.7,129.1,128.8,128.6,128.2,127.7,127.2,67.8,57.7,35.2。
实施例20
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成苯基异丙基砜二亚胺,其它与实施例1的相同,产率为47%。
实施例20产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.81-7.71(m,2H),7.61-7.52(m,3H),7.42-7.38(m,2H),7.34-7.29(m,3H),5.06(dd,J1=23.2Hz,J2=12.4Hz,2H),3.46(m,1H),1.40(d,J=6.8Hz,3H),1.19(d,J=6.8Hz,3H);
13C NMR(100MHz,CDCl3)δ137.3,136.4,132.3,129.9,128.2,128.1,127.6,126.2,67.6,21.7,15.9,15.2。
实施例21
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成苯基正丁基砜二亚胺,其它与实施例1的相同,产率为50%。
实施例21产物的核磁表征数据为:
实施例21:1H NMR(400MHz,CDCl3)δ7.78-7.70(m,2H),7.57-7.51(m,3H),7.45-7.37(m,2H),7.32-7.22(m,3H),5.13(dd,J1=23.2Hz,J2=12.4Hz,2H),3.16-3.08(m,2H),1.80-1.69(m,2H),1.37-1.20(m,2H),0.85(t,J=7.0Hz,3H);
13C NMR(100MHz,CDCl3)δ137.3,136.4,132.3,129.9,128.2,128.1,127.6,126.2,58.1,31.0,22.7,13.8。
实施例22
一种光催化合成N-取代砜二亚胺的方法,其合成路线如下:
将实施例1中的甲基苯基砜二亚胺换成苯基烯丙基砜二亚胺,其它与实施例1的相同,产率为51%。
实施例22产物的核磁表征数据为:
1H NMR(400MHz,CDCl3)δ7.86(m,2H),7.65-7.59(m,3H),7.34-7.27(m,3H),6.99(d,J=9.0Hz,2H),5.88-5.79(m,1H),5.34-5.31(m,1H),5.15-5.11(m,1H),5.06(m,2H),3.89-3.77(m,2H);
13C NMR(100MHz,CDCl3)δ136.1,134.2,133.1,132.3,131.1,128.1,125.8,124.4,114.3,62.8,59.8。
表1为本发明实施例1-8的反应底物、碱和溶剂及产率
尽管本发明的内容已经通过上述优选实施例作了详细介绍,但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后,对于本发明的多种修改和替代都将是显而易见的。因此,本发明的保护范围应由所附的权利要求来限定。
Claims (9)
2.根据权利要求1所述的方法,其特征在于,所述R1选自苯基、对甲基苯基、对甲氧基苯基、对氯苯基、对溴苯基、五元或六元含氮芳香杂环、五元含硫芳香杂环和五元含氧芳香杂环中的任意一种。
6.根据权利要求1-5中任意一项所述的方法,其特征在于,所述R3选自苯基、C1~C4的饱和烷烃和C2~C4的烯烃中的任意一种。
7.根据权利要求1所述的方法,其特征在于,所述白光灯的功率为5W。
8.根据权利要求1所述的方法,其特征在于,所述无机碱选自碳酸盐和/或碳酸氢盐;所述碳酸盐选自碳酸钠和/或碳酸钾;所述碳酸氢盐选自碳酸氢钠和/或碳酸氢钾。
9.根据权利要求1所述的方法,其特征在于,所述非质子溶剂选自四氢呋喃、甲苯和乙醚中的任意一种或两种以上。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010813444.2A CN111925308B (zh) | 2020-08-13 | 2020-08-13 | 一种光催化合成n-取代砜二亚胺的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010813444.2A CN111925308B (zh) | 2020-08-13 | 2020-08-13 | 一种光催化合成n-取代砜二亚胺的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111925308A CN111925308A (zh) | 2020-11-13 |
CN111925308B true CN111925308B (zh) | 2022-03-22 |
Family
ID=73311723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010813444.2A Active CN111925308B (zh) | 2020-08-13 | 2020-08-13 | 一种光催化合成n-取代砜二亚胺的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111925308B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013049021A1 (en) * | 2011-09-29 | 2013-04-04 | Janssen Pharmaceutica Nv | Process for the preparation of sulfamide derivatives |
WO2016037592A1 (zh) * | 2014-09-12 | 2016-03-17 | 苏州旺山旺水生物医药有限公司 | 一种氨基磺酰基类化合物、其制备方法及用途 |
CN109516937A (zh) * | 2018-10-31 | 2019-03-26 | 成都理工大学 | 一种亚砜亚胺酰基化物的合成方法 |
-
2020
- 2020-08-13 CN CN202010813444.2A patent/CN111925308B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013049021A1 (en) * | 2011-09-29 | 2013-04-04 | Janssen Pharmaceutica Nv | Process for the preparation of sulfamide derivatives |
WO2016037592A1 (zh) * | 2014-09-12 | 2016-03-17 | 苏州旺山旺水生物医药有限公司 | 一种氨基磺酰基类化合物、其制备方法及用途 |
CN106687449A (zh) * | 2014-09-12 | 2017-05-17 | 苏州旺山旺水生物医药有限公司 | 一种氨基磺酰基类化合物、其制备方法及用途 |
CN109516937A (zh) * | 2018-10-31 | 2019-03-26 | 成都理工大学 | 一种亚砜亚胺酰基化物的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111925308A (zh) | 2020-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109651210B (zh) | 一种3-磺酰基-1,2-二氢化萘化合物的制备方法 | |
CN109081807A (zh) | 一种制备三取代4-氨基咔唑类和二取代1-氨基二苯并[b,d]噻吩类化合物的方法 | |
CN111925356B (zh) | 手性喹啉-咪唑啉配体的合成方法及其应用 | |
CN111925308B (zh) | 一种光催化合成n-取代砜二亚胺的方法 | |
Liu et al. | Reagents for direct trifluoromethylthiolation | |
Müller et al. | Rh (II)-catalyzed asymmetric cyclopropenation of propargyl derivatives; synthesis of cyclopropene-and cis-cyclopropane-amino acids | |
CN113666826B (zh) | 一种芳基或杂芳基甲氧基化反应的方法 | |
CN110540516B (zh) | 一种1-磺酰甲基-3,4-二氢萘的制备方法 | |
CN113754604B (zh) | 一类含氮手性配体及其在硫醚的不对称氧化反应中的应用 | |
CN111116461B (zh) | 一种钯催化邻甲苯吡啶酰胺γ-C-(sp3)H硫/硒醚类化合物的合成方法 | |
CN109438299B (zh) | 一种苯磺酰肼类衍生物与三乙胺无金属催化合成苯磺酰烯胺类化合物的方法 | |
KR20060131497A (ko) | 구리 촉매하의 삼성분 짝지움 반응에 의한n-술포닐아미딘의 제조방법 | |
CN109232564B (zh) | 一种分子碘促进的一锅法合成3位硫基取代咪唑并[1,2-a]吡啶化合物的方法 | |
CN111960975A (zh) | 一种烯丙基硫醚类化合物及其制备方法 | |
CN112824372A (zh) | 铜催化烯烃的不对称环丙烷化方法及其应用 | |
CN110590641B (zh) | 一种3-羟基异吲哚-1-酮系列化合物的绿色制备方法 | |
CN114605273B (zh) | 一种钯催化co参与的1,4-烯炔芳构化反应合成芳胺基酚类化合物的方法 | |
CN114213298B (zh) | 一种由硫酚直接氧化制备硫代磺酸酯类化合物的方法 | |
CN108947995A (zh) | 一种多取代噁二嗪衍生物的制备方法 | |
CN115572248B (zh) | 一种制备β-氨基砜类化合物的方法 | |
CN109810056B (zh) | S-烷基-s-喹啉基-n-磺酰基氮硫叶立德化合物及其制备和应用 | |
CN110590621B (zh) | 一种铜催化端炔合成1,2-双(芳基磺酰基)乙烯衍生物的方法 | |
CN113845550B (zh) | 一种含有卤代苯环的柔性大位阻n-杂环卡宾钯配合物和制备方法及其应用 | |
CN111875544B (zh) | 一种n-取代乙内酰脲类化合物的合成方法 | |
JP2003206282A (ja) | オキサゾリジン−2−オン誘導体の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |